G. Eskiizmir, G. Çalıbaşı, T. Uysal, H. Ellidokuz, and Y. Baskın, “Cetuximab alone has a dose-dependent antitumor effect in oral cavity cancer cells: an in vitro study”, ENTU, vol. 6, no. 3, Feb. 2016.